Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 373

Similar articles for PubMed (Select 16970062)

1.

Regression of left ventricular hypertrophy during antihypertensive treatment.

Foading Deffo B.

Acta Cardiol. 2006 Aug;61(4):485-8.

PMID:
16970062
2.

[Left ventricular hypertrophy and cardiovascular risk in hypertension].

Amabile G.

Ann Cardiol Angeiol (Paris). 1998 Feb;47(2):86-90. Review. French.

PMID:
9772934
3.

Left bundle branch block and cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension study.

Li Z, Dahlöf B, Okin PM, Kjeldsen SE, Wachtell K, Ibsen H, Nieminen MS, Jern S, Devereux RB.

J Hypertens. 2008 Jun;26(6):1244-9. doi: 10.1097/HJH.0b013e3282fcc23c.

PMID:
18475164
4.

Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study.

Wachtell K, Okin PM, Olsen MH, Dahlöf B, Devereux RB, Ibsen H, Kjeldsen SE, Lindholm LH, Nieminen MS, Thygesen K.

Circulation. 2007 Aug 14;116(7):700-5. Epub 2007 Jul 30.

5.

Baroreceptor sensitivity, cardiovascular responses and ECG left ventricular hypertrophy in men: the SABPA study.

van Lill L, Malan L, van Rooyen J, Steyn F, Reimann M, Ziemssen T.

Blood Press. 2011 Dec;20(6):355-61. doi: 10.3109/08037051.2011.580529. Epub 2011 May 6.

PMID:
21545353
6.

Regression of left ventricular hypertrophy in hypertension--does it reduce cardiovascular risk?

Braz Nogueira J.

Rev Port Cardiol. 2005 Jul-Aug;24(7-8):1007-13. Review. English, Portuguese.

7.

High prevalence of target organ damage in young, African American inner-city men with hypertension.

Post WS, Hill MN, Dennison CR, Weiss JL, Gerstenblith G, Blumenthal RS.

J Clin Hypertens (Greenwich). 2003 Jan-Feb;5(1):24-30.

PMID:
12556650
8.

[Regression of left ventricular hypertrophy with antihypertensive therapy].

Follath F.

Ther Umsch. 1998 Sep;55(9):539-41. German.

PMID:
9789465
9.

Regression of echocardiographic left ventricular hypertrophy after 2 years of therapy reduces cardiovascular risk in patients with essential hypertension.

Pierdomenico SD, Lapenna D, Cuccurullo F.

Am J Hypertens. 2008 Apr;21(4):464-70. doi: 10.1038/ajh.2008.2. Epub 2008 Feb 7.

PMID:
18369364
10.

Left ventricular hypertrophy in African Black patients with chronic renal failure at first evaluation.

Ulasi II, Arodiwe EB, Ijoma CK.

Ethn Dis. 2006 Autumn;16(4):859-64.

PMID:
17061738
11.

[Cardiac failure in hypertensive cardiopathy].

Verdecchia P.

Ital Heart J. 2000 Jun;1 Suppl 2:72-7. Review. Italian.

PMID:
10905132
12.

[Arterial hypertension, left ventricular hypertrophy and antihypertensive treatment].

de la Figuera M.

Aten Primaria. 1995 Apr 15;15(6):339-40. Spanish. No abstract available.

PMID:
7749022
13.

Race and hypertensive target-organ damage in patients from an university-affiliated outpatient care referral clinic in the city of Salvador.

Noblat AC, Lopes MB, Lopes AA.

Arq Bras Cardiol. 2004 Feb;82(2):116-20, 111-5. Epub 2004 Mar 17. English, Portuguese.

14.

Left atrial size and risk of major cardiovascular events during antihypertensive treatment: losartan intervention for endpoint reduction in hypertension trial.

Gerdts E, Wachtell K, Omvik P, Otterstad JE, Oikarinen L, Boman K, Dahlöf B, Devereux RB.

Hypertension. 2007 Feb;49(2):311-6. Epub 2006 Dec 18.

15.

Regression of left ventricular hypertrophy and cardiovascular risk changes in hypertensive patients.

Verdecchia P, Angeli F, Pittavini L, Gattobigio R, Benemio G, Porcellati C.

Ital Heart J. 2004 Jul;5(7):505-10. Review.

PMID:
15487267
16.

[Regression of left ventricular hypertrophy in hypertensive heart disease].

Hennersdorf MG, Schannwell CM, Schwartzkopff B, Strauer BE.

Herz. 2003 Dec;28(8):764-78. German.

PMID:
14689112
17.

[The heart in hypertension].

Hennersdorf MG, Strauer BE.

Internist (Berl). 2007 Mar;48(3):236-45. Review. German.

PMID:
17260148
18.

Antihypertensive drugs and the heart.

Diamond JA, Phillips RA.

Minerva Med. 2005 Aug;96(4):247-60. Review.

PMID:
16179892
19.

Gender differences in left ventricular structure and function during antihypertensive treatment: the Losartan Intervention for Endpoint Reduction in Hypertension Study.

Gerdts E, Okin PM, de Simone G, Cramariuc D, Wachtell K, Boman K, Devereux RB.

Hypertension. 2008 Apr;51(4):1109-14. doi: 10.1161/HYPERTENSIONAHA.107.107474. Epub 2008 Feb 7.

20.

Regression of electrocardiographic left ventricular hypertrophy is associated with less hospitalization for heart failure in hypertensive patients.

Okin PM, Devereux RB, Harris KE, Jern S, Kjeldsen SE, Julius S, Edelman JM, Dahlöf B; LIFE Study Investigators.

Ann Intern Med. 2007 Sep 4;147(5):311-9.

PMID:
17785486
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk